Rafferty Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Other funds holding VNDA
ACM
Rafferty Asset Management's VNDA Position: Q3 2026 in Review
Rafferty Asset Management increased its Vanda Pharmaceuticals (VNDA) stake by 22% in Q3 2026, buying an estimated $74.9K and bringing the position to 77,644 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #938.
Rafferty Asset Management first reported a position in VNDA in Q1 2019 and has held it in 20 quarters since. The position peaked at $3.03M in Q1 2019. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.
- Rafferty Asset Management held 77,644 shares of Vanda Pharmaceuticals worth $381K as of Q3 2026.
- Rafferty Asset Management bought 13,941 Vanda Pharmaceuticals shares in Q3 2026, an estimated $74.9K.
- Vanda Pharmaceuticals made up ﹤0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #938 holding.
- Rafferty Asset Management first reported a position in Vanda Pharmaceuticals in Q1 2019 and has held it in 20 quarters since.
- Rafferty Asset Management's Vanda Pharmaceuticals position peaked at $3.03M in Q1 2019.
- 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.